Lates News
Lycome: building a new manufacturing plant in Katwijk, Netherlands costing $300 million, the plant will create 500 manufacturing jobs and 1500 construction jobs. The Dutch production base will be involved in the production of the oral GLP-1 drug Orforglipron; it is expected to submit a marketing application for this obesity treatment drug to global regulatory agencies by the end of 2025.
Latest

